Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation.

Yang H, Qiu Q, Gao B, Kong S, Lin Z, Fang D.

J Exp Med. 2014 Nov 17;211(12):2467-79. doi: 10.1084/jem.20140283. Epub 2014 Nov 3.

2.

Increased IFN-α-producing plasmacytoid dendritic cells (pDCs) in human Th1-mediated type 1 diabetes: pDCs augment Th1 responses through IFN-α production.

Xia CQ, Peng R, Chernatynskaya AV, Yuan L, Carter C, Valentine J, Sobel E, Atkinson MA, Clare-Salzler MJ.

J Immunol. 2014 Aug 1;193(3):1024-34. doi: 10.4049/jimmunol.1303230. Epub 2014 Jun 27.

3.

Comparative analysis of gingival tissue antigen presentation pathways in ageing and periodontitis.

Gonzalez OA, Novak MJ, Kirakodu S, Orraca L, Chen KC, Stromberg A, Gonzalez-Martinez J, Ebersole JL.

J Clin Periodontol. 2014 Apr;41(4):327-39. doi: 10.1111/jcpe.12212. Epub 2014 Jan 7.

4.

Role of Sug1, a 19S proteasome ATPase, in the transcription of MHC I and the atypical MHC II molecules, HLA-DM and HLA-DO.

Inostroza-Nieves Y, Venkatraman P, Zavala-Ruiz Z.

Immunol Lett. 2012 Sep;147(1-2):67-74. doi: 10.1016/j.imlet.2012.06.005. Epub 2012 Jul 4.

5.

Dysregulated recruitment of the histone methyltransferase EZH2 to the class II transactivator (CIITA) promoter IV in breast cancer cells.

Truax AD, Thakkar M, Greer SF.

PLoS One. 2012;7(4):e36013. doi: 10.1371/journal.pone.0036013. Epub 2012 Apr 26.

6.

MHC class II upregulation and colocalization with Fas in experimental models of immune-mediated bone marrow failure.

Erie AJ, Samsel L, Takaku T, Desierto MJ, Keyvanfar K, McCoy JP, Young NS, Chen J.

Exp Hematol. 2011 Aug;39(8):837-49. doi: 10.1016/j.exphem.2011.05.005. Epub 2011 May 13.

7.

HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition.

Campoli M, Ferrone S.

Semin Immunopathol. 2011 Jul;33(4):321-34. doi: 10.1007/s00281-011-0270-z. Epub 2011 Apr 28. Review.

8.

Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.

Smith MA, Wright G, Wu J, Tailor P, Ozato K, Chen X, Wei S, Piskurich JF, Ting JP, Wright KL.

J Biol Chem. 2011 Mar 11;286(10):7893-904. doi: 10.1074/jbc.M110.165431. Epub 2011 Jan 7.

9.

Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.

Burster T, Macmillan H, Hou T, Schilling J, Truong P, Boehm BO, Zou F, Lau K, Strohman M, Schaffert S, Busch R, Mellins ED.

Immunology. 2010 Jul;130(3):436-46. doi: 10.1111/j.1365-2567.2010.03247.x. Epub 2010 Mar 17. Erratum in: Immunology. 2010 Nov;131(3):450.

10.

RFX2 is a candidate downstream amplifier of A-MYB regulation in mouse spermatogenesis.

Horvath GC, Kistler MK, Kistler WS.

BMC Dev Biol. 2009 Dec 9;9:63. doi: 10.1186/1471-213X-9-63.

11.

Distinct MHC gene expression patterns during progression of melanoma.

Degenhardt Y, Huang J, Greshock J, Horiates G, Nathanson K, Yang X, Herlyn M, Weber B.

Genes Chromosomes Cancer. 2010 Feb;49(2):144-54. doi: 10.1002/gcc.20728.

12.

Operons.

Osbourn AE, Field B.

Cell Mol Life Sci. 2009 Dec;66(23):3755-75. doi: 10.1007/s00018-009-0114-3. Epub 2009 Aug 7. Review.

13.

Differential expression of Rfx1-4 during mouse spermatogenesis.

Kistler WS, Horvath GC, Dasgupta A, Kistler MK.

Gene Expr Patterns. 2009 Oct;9(7):515-9. doi: 10.1016/j.gep.2009.07.004. Epub 2009 Jul 19.

14.

Identification of a novel DPA1 allele, DPA1*010602, in an East African population.

Peterson TA, Luo M, Mao X, Brunham RC, Plummer FA.

Hum Immunol. 2008 Dec;69(12):885-6. doi: 10.1016/j.humimm.2008.09.001. Epub 2008 Oct 7.

15.

Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production.

Saito K, Ait-Goughoulte M, Truscott SM, Meyer K, Blazevic A, Abate G, Ray RB, Hoft DF, Ray R.

J Virol. 2008 Apr;82(7):3320-8. doi: 10.1128/JVI.02547-07. Epub 2008 Jan 23.

16.

The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes.

Thompson JA, Srivastava MK, Bosch JJ, Clements VK, Ksander BR, Ostrand-Rosenberg S.

Cancer Immunol Immunother. 2008 Mar;57(3):389-98. Epub 2007 Aug 28.

17.

The zinc finger proteins ZXDA and ZXDC form a complex that binds CIITA and regulates MHC II gene transcription.

Al-Kandari W, Koneni R, Navalgund V, Aleksandrova A, Jambunathan S, Fontes JD.

J Mol Biol. 2007 Jun 22;369(5):1175-87. Epub 2007 Apr 19.

18.

Hexim1 sequesters positive transcription elongation factor b from the class II transactivator on MHC class II promoters.

Kohoutek J, Blazek D, Peterlin BM.

Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17349-54. Epub 2006 Nov 6.

Items per page

Supplemental Content

Write to the Help Desk